Pan-cancer analysis reveals the oncogenic and immunomodulatory roles of PTGFRN across human cancers
Crossref DOI link: https://doi.org/10.1038/s41598-026-41027-y
Published Online: 2026-02-27
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mu, Nan
Dong, Tianjian
Sheng, Qingyu
Duan, Zhuoning
Wang, Xiangming
Zhao, Qi
Text and Data Mining valid from 2026-02-27
Accepted Manuscript valid from 2026-02-27
Article History
Received: 21 October 2025
Accepted: 17 February 2026
First Online: 27 February 2026
Declarations
:
: The authors declare no competing interests.